ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 71. Num. 6.
Pages 508 (June 2018)

Corrections
Correction in Article by Vaglimi et al. “2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease Developed in Collaboration with EACTS”, Rev Esp Cardiol. 2018;71:42.e1-e58

Corrección en el artículo de Vaglimi et al. “Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS”, Rev Esp Cardiol. 2018;71:42.e1-e58

Rev Esp Cardiol. 2018;71:4210.1016/j.rec.2017.11.020
Marco Valgimigli, Héctor Bueno, Robert A. Byrne, Jean-Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe Kolh, Laura Mauri, Gilles Montalescot, Franz-Josef Neumann, Mate Petricevic, Marco Roffi, Philippe Gabriel Steg, Stephan Windecker, José Luis Zamorano

Options

In the article by Vaglimi et al. entitled, “2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS” (Rev Esp Cardiol. 2018;71:42.e1-e58), an error has been detected in Figure 7.

Figure 7
(0.37MB).

In the lower part of the figure, “O = Ticagrelor” should be “O = Anticoagulación oral”. This error only appears in the Spanish version of the article.

The correct figure is:

Insert here the figure attached.

This correction was introduced in the electronic version of the article on 21 March 2018.

-----

SEE RELATED CONTENT: https://doi.org/10.1016/j.recesp.2017.11.014

Are you a healthcare professional authorized to prescribe or dispense medications?